We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

ALCOR Scientific Inc.

ALCOR Scientific develops and manufactures proprietary devices for the clinical diagnostics and enteral feeding devic... read more Featured Products: More products

Download Mobile App





Alcor Scientific Demonstrates Fully-Automated ESR Analyzers

By LabMedica International staff writers
Posted on 14 Nov 2023
Print article
Image: The iSED fully-automated ESR analyzer is on display at MEDICA 2023 (Photo courtesy of ALCOR)
Image: The iSED fully-automated ESR analyzer is on display at MEDICA 2023 (Photo courtesy of ALCOR)

ALCOR Scientific (Smithfield, RI, USA) is demonstrating its innovative diagnostic instrumentation and medical devices for the healthcare industry at MEDICA 2023.

Visitors to the ALCOR booth can take a close look at the iSED ESR Analyzer and the miniiSED ESR Analyzer which provide virtually instantaneous results with a fully automated workflow. ALCOR’s iSED capillary photometry technology is based on syllectometry. Photometric rheology is used to quantify the rouleaux formation, which is the earliest and most critical phase of red blood cell sedimentation. Red blood cells are injected into the iSED analyzers’ flow cell which causes them to disaggregate. The flow cell sensors capture the difference in light transmission over time as the injected red blood cells begin to re-aggregate.

The technical innovation of ALCOR’s ESR analyzers consists of “directly” measuring the aggregation of the red blood cells, whereas the traditional methods “indirectly” measure the aggregation of the red blood cells by recording the length at which the red cells settle in a Westergren tube. Like traditional ESR testing, iSED results are provided in mm/hr. iSED technology is highly correlated to the Westergren method, and test results are available in just 15-20 seconds without the drawbacks and inconvenience of traditional ESR testing.

At MEDICA 2023, ALCOR is also presenting SENTINELplus Enteral Feeding Pump which is an enhanced version of the company’s popular SENTINEL feeding pump. It delivers the same simplicity and reliability as its predecessor in a lighter and smaller package. Its bright LED display allows caregivers to simultaneously and conveniently view the infusion rate and volume delivered from a distance. Additionally, the pump retains the operating history until manually erased, even in the event of power failures or when it is turned off. ALCOR is highlighting its SEDiTROL Quality Controls which are bi-level, human-based, whole-blood external controls used to monitor the performance of the iSED, iSED ELITE, and miniiSED ESR analyzers and testing techniques. SEDiTROL controls are derived from human blood to mimic a patient sample and are processed in the same manner as a patient sample. For efficiency and convenience, the controls are stored at room temperature and can be placed directly into the analyzer.

Related Links:
ALCOR Scientific

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Liquid Ready-To-Use Lp(a) Reagent
Lipoprotein (a) Reagent

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Molecular Diagnostics

view channel
Image: Researchers have found the first evidence of testing for the alpha-synuclein protein in blood samples via seed amplification assay (Photo courtesy of Shutterstock)

Blood Test to Detect Alpha-Synuclein Protein Could Revolutionize Parkinson's Disease Diagnostics

Currently, Parkinson's disease (PD) is identified through clinical diagnosis, typically at a later stage in the disease's progression. There is a pressing need for an objective and quantifiable biomarker... Read more

Hematology

view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Microbiology

view channel
Image: Ultra-Rapid Antimicrobial Susceptibility Testing (uRAST) revolutionizing traditional antibiotic susceptibility testing (Photo courtesy of Seoul National University)

Ultra-Rapid Culture-Free Sepsis Test Reduces Testing Time from Days to Hours

Sepsis, a critical emergency condition, results from an overactive inflammatory response to pathogens like bacteria or fungi in the blood, leading to organ damage and the possibility of sudden death.... Read more

Pathology

view channel
Image: The AI model can distinguish different stages of DCIS from inexpensive and readily available breast tissue images (Photo courtesy of David A. Litman/Shutterstock)

AI Model Identifies Breast Tumor Stages Likely To Progress to Invasive Cancer

Ductal carcinoma in situ (DCIS) is a non-invasive type of tumor that can sometimes progress to a more lethal form of breast cancer and represents about 25% of all breast cancer cases. Between 30% and 50%... Read more

Industry

view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.